Analysts expect Healthequity Inc (NASDAQ:HQY) to report $58.46 million in sales for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for Healthequity’s earnings. The lowest sales estimate is $57.38 million and the highest is $59.09 million. Healthequity posted sales of $46.81 million during the same quarter last year, which would suggest a positive year over year growth rate of 24.9%. The business is expected to report its next earnings results after the market closes on Tuesday, March 20th.
According to Zacks, analysts expect that Healthequity will report full year sales of $58.46 million for the current year, with estimates ranging from $226.46 million to $228.00 million. For the next financial year, analysts anticipate that the firm will report sales of $277.59 million per share, with estimates ranging from $272.92 million to $279.93 million. Zacks’ sales calculations are an average based on a survey of research firms that cover Healthequity.
Healthequity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm had revenue of $56.80 million during the quarter, compared to analyst estimates of $55.27 million. During the same period last year, the company posted $0.10 EPS. The business’s quarterly revenue was up 31.0% on a year-over-year basis.
Healthequity (NASDAQ:HQY) traded up $1.77 during mid-day trading on Friday, hitting $52.51. The stock had a trading volume of 1,727,136 shares, compared to its average volume of 660,364. Healthequity has a 1 year low of $37.62 and a 1 year high of $57.72. The company has a market cap of $3,078.53, a price-to-earnings ratio of 70.95, a PEG ratio of 1.94 and a beta of 1.70.
In other Healthequity news, insider Jon Kessler sold 59,558 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $55.32, for a total transaction of $3,294,748.56. Following the completion of the sale, the insider now directly owns 504,558 shares of the company’s stock, valued at approximately $27,912,148.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Frank Medici sold 13,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $52.14, for a total value of $677,820.00. Following the sale, the director now directly owns 6,381 shares of the company’s stock, valued at $332,705.34. The disclosure for this sale can be found here. Insiders sold a total of 724,137 shares of company stock valued at $37,502,418 over the last ninety days. 29.00% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently modified their holdings of the business. Zions Bancorporation bought a new stake in Healthequity during the 3rd quarter worth approximately $119,000. Catalyst Capital Advisors LLC bought a new stake in Healthequity during the 4th quarter worth approximately $149,000. CIBC Asset Management Inc bought a new stake in Healthequity during the 3rd quarter worth approximately $208,000. Fortaleza Asset Management Inc. increased its holdings in Healthequity by 56.0% during the 3rd quarter. Fortaleza Asset Management Inc. now owns 4,330 shares of the company’s stock worth $219,000 after purchasing an additional 1,555 shares in the last quarter. Finally, Ameritas Investment Partners Inc. increased its holdings in Healthequity by 17.4% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,375 shares of the company’s stock worth $218,000 after purchasing an additional 648 shares in the last quarter. 99.47% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://sportsperspectives.com/2018/02/24/healthequity-inc-hqy-expected-to-post-quarterly-sales-of-58-46-million-2.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.